메뉴 건너뛰기




Volumn 143, Issue 1, 2010, Pages 35-42

Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population

Author keywords

Cardiovascular disease; Cardiovascular mortality; Low grade inflammation; Overall mortality; Type 2 diabetes; YKL 40

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; LIPID; PROTEIN; UNCLASSIFIED DRUG; YKL 40 PROTEIN; ADIPOCYTOKINE; BIOLOGICAL MARKER; CHI3L1 PROTEIN, HUMAN; GLYCOPROTEIN; LECTIN;

EID: 77955656150     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.01.043     Document Type: Article
Times cited : (70)

References (34)
  • 1
    • 0042195833 scopus 로고    scopus 로고
    • Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
    • P. Greenland, M.D. Knoll, and J. Stamler Major risk factors as antecedents of fatal and nonfatal coronary heart disease events JAMA 290 2003 891 897
    • (2003) JAMA , vol.290 , pp. 891-897
    • Greenland, P.1    Knoll, M.D.2    Stamler, J.3
  • 2
    • 0042697063 scopus 로고    scopus 로고
    • Prevalence of conventional risk factors in patients with coronary heart disease
    • U.N. Khot, M.B. Khot, and C.T. Bajzer Prevalence of conventional risk factors in patients with coronary heart disease JAMA 290 2003 898 904
    • (2003) JAMA , vol.290 , pp. 898-904
    • Khot, U.N.1    Khot, M.B.2    Bajzer, C.T.3
  • 3
    • 0037078969 scopus 로고    scopus 로고
    • Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
    • P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
    • (2002) N Engl J Med , vol.347 , pp. 1557-1565
    • Ridker, P.M.1    Rifai, N.2    Rose, L.3    Buring, J.E.4    Cook, N.R.5
  • 4
    • 0027406191 scopus 로고
    • Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
    • J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
    • (1993) Diabetes Care , vol.16 , pp. 434-444
    • Stamler, J.1    Vaccaro, O.2    Neaton, J.D.3    Wentworth, D.4
  • 6
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
    • (1998) N Engl J Med , vol.339 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Ronnemaa, T.3    Pyorala, K.4    Laakso, M.5
  • 7
    • 0035908632 scopus 로고    scopus 로고
    • C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
    • A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
    • (2001) JAMA , vol.286 , pp. 327-334
    • Pradhan, A.D.1    Manson, J.E.2    Rifai, N.3    Buring, J.E.4    Ridker, P.M.5
  • 8
    • 0038691972 scopus 로고    scopus 로고
    • Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study
    • B.B. Duncan, M.I. Schmidt, and J.S. Pankow Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 52 2003 1799 1805
    • (2003) Diabetes , vol.52 , pp. 1799-1805
    • Duncan, B.B.1    Schmidt, M.I.2    Pankow, J.S.3
  • 9
    • 0037022910 scopus 로고    scopus 로고
    • Inflammation and atherosclerosis
    • P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
    • (2002) Circulation , vol.105 , pp. 1135-1143
    • Libby, P.1    Ridker, P.M.2    Maseri, A.3
  • 10
    • 0142061128 scopus 로고    scopus 로고
    • Circulating markers of inflammation and atherosclerosis
    • L. Lind Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2003 203 214
    • (2003) Atherosclerosis , vol.169 , pp. 203-214
    • Lind, L.1
  • 11
    • 1442275317 scopus 로고    scopus 로고
    • Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
    • J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 2004 813 823
    • (2004) Diabetes Care , vol.27 , pp. 813-823
    • Pickup, J.C.1
  • 12
    • 2142649221 scopus 로고    scopus 로고
    • Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus
    • J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
    • (2004) JAMA , vol.291 , pp. 1978-1986
    • Meigs, J.B.1    Hu, F.B.2    Rifai, N.3    Manson, J.E.4
  • 13
    • 0035897688 scopus 로고    scopus 로고
    • Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
    • P.M. Ridker, M.J. Stampfer, and N. Rifai Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
    • (2001) JAMA , vol.285 , pp. 2481-2485
    • Ridker, P.M.1    Stampfer, M.J.2    Rifai, N.3
  • 14
    • 21344460247 scopus 로고    scopus 로고
    • An immune origin of type 2 diabetes?
    • H. Kolb, and T. Mandrup-Poulsen An immune origin of type 2 diabetes? Diabetologia 48 2005 1038 1050
    • (2005) Diabetologia , vol.48 , pp. 1038-1050
    • Kolb, H.1    Mandrup-Poulsen, T.2
  • 15
    • 15944419583 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
    • C. Kistorp, I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults JAMA 293 2005 1609 1616
    • (2005) JAMA , vol.293 , pp. 1609-1616
    • Kistorp, C.1    Raymond, I.2    Pedersen, F.3    Gustafsson, F.4    Faber, J.5    Hildebrandt, P.6
  • 16
    • 34548425213 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population
    • M.H. Olsen, T.W. Hansen, and M.K. Christensen N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur Heart J 28 2007 1374 1381
    • (2007) Eur Heart J , vol.28 , pp. 1374-1381
    • Olsen, M.H.1    Hansen, T.W.2    Christensen, M.K.3
  • 17
    • 23844491509 scopus 로고    scopus 로고
    • Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study
    • J. Arnlov, J.C. Evans, and J.B. Meigs Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study Circulation 112 2005 969 975
    • (2005) Circulation , vol.112 , pp. 969-975
    • Arnlov, J.1    Evans, J.C.2    Meigs, J.B.3
  • 18
    • 33748485114 scopus 로고    scopus 로고
    • YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis
    • C.N. Rathcke, and H. Vestergaard YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis Inflamm Res 55 2006 221 227
    • (2006) Inflamm Res , vol.55 , pp. 221-227
    • Rathcke, C.N.1    Vestergaard, H.2
  • 19
    • 0022453659 scopus 로고
    • In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells
    • A.J. Millis, M. Hoyle, and L. Kent In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells J Cell Physiol 127 1986 366 372
    • (1986) J Cell Physiol , vol.127 , pp. 366-372
    • Millis, A.J.1    Hoyle, M.2    Kent, L.3
  • 20
    • 0029039184 scopus 로고
    • Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling
    • L.M. Shackelton, D.M. Mann, and A.J. Millis Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling J Biol Chem 270 1995 13076 13083
    • (1995) J Biol Chem , vol.270 , pp. 13076-13083
    • Shackelton, L.M.1    Mann, D.M.2    Millis, A.J.3
  • 21
    • 0031470037 scopus 로고    scopus 로고
    • Smooth muscle migration in vascular development and pathogenesis
    • S.M. Schwartz Smooth muscle migration in vascular development and pathogenesis Transpl Immunol 5 1997 255 260
    • (1997) Transpl Immunol , vol.5 , pp. 255-260
    • Schwartz, S.M.1
  • 22
    • 0037530029 scopus 로고    scopus 로고
    • Gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells
    • K.C. Nishikawa, and A.J. Millis gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells Exp Cell Res 287 2003 79 87
    • (2003) Exp Cell Res , vol.287 , pp. 79-87
    • Nishikawa, K.C.1    Millis, A.J.2
  • 23
    • 0032975495 scopus 로고    scopus 로고
    • Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages
    • R.G. Boot, T.A. van Achterberg, and B.E. van Aken Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages Arterioscler Thromb Vasc Biol 19 1999 687 694
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 687-694
    • Boot, R.G.1    Van Achterberg, T.A.2    Van Aken, B.E.3
  • 24
    • 12744279375 scopus 로고    scopus 로고
    • In vitro biomarker discovery for atherosclerosis by proteomics
    • E.M. Fach, L.A. Garulacan, and J. Gao In vitro biomarker discovery for atherosclerosis by proteomics Mol Cell Proteomics 3 2004 1200 1210
    • (2004) Mol Cell Proteomics , vol.3 , pp. 1200-1210
    • Fach, E.M.1    Garulacan, L.A.2    Gao, J.3
  • 25
    • 33645815907 scopus 로고    scopus 로고
    • YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance
    • C.N. Rathcke, J.S. Johansen, and H. Vestergaard YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance Inflamm Res 55 2006 53 59
    • (2006) Inflamm Res , vol.55 , pp. 53-59
    • Rathcke, C.N.1    Johansen, J.S.2    Vestergaard, H.3
  • 26
    • 0344974146 scopus 로고    scopus 로고
    • The Frederiksberg Heart Failure Study: Rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population
    • I. Raymond, F. Pedersen, M. Busch-Sorensen, A. Green, and P.R. Hildebrandt The Frederiksberg Heart Failure Study: rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population HeartDrug 2002 2002 167 174
    • (2002) HeartDrug , vol.2002 , pp. 167-174
    • Raymond, I.1    Pedersen, F.2    Busch-Sorensen, M.3    Green, A.4    Hildebrandt, P.R.5
  • 27
    • 3142735789 scopus 로고    scopus 로고
    • The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20 years of follow-up
    • T. Almdal, H. Scharling, J.S. Jensen, and H. Vestergaard The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up Arch Intern Med 164 2004 1422 1426
    • (2004) Arch Intern Med , vol.164 , pp. 1422-1426
    • Almdal, T.1    Scharling, H.2    Jensen, J.S.3    Vestergaard, H.4
  • 28
    • 37849030677 scopus 로고    scopus 로고
    • High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality
    • J.S. Johansen, A.N. Pedersen, M. Schroll, T. Jorgensen, B.K. Pedersen, and H. Bruunsgaard High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality Clin Exp Immunol 151 2008 260 266
    • (2008) Clin Exp Immunol , vol.151 , pp. 260-266
    • Johansen, J.S.1    Pedersen, A.N.2    Schroll, M.3    Jorgensen, T.4    Pedersen, B.K.5    Bruunsgaard, H.6
  • 29
    • 36148981436 scopus 로고    scopus 로고
    • A chitinase-like protein in the lung and circulation of patients with severe asthma
    • G.L. Chupp, C.G. Lee, and N. Jarjour A chitinase-like protein in the lung and circulation of patients with severe asthma N Engl J Med 357 2007 2016 2027
    • (2007) N Engl J Med , vol.357 , pp. 2016-2027
    • Chupp, G.L.1    Lee, C.G.2    Jarjour, N.3
  • 30
    • 33646842919 scopus 로고    scopus 로고
    • Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer
    • J.S. Johansen Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer Dan Med Bull 53 2006 172 209
    • (2006) Dan Med Bull , vol.53 , pp. 172-209
    • Johansen, J.S.1
  • 32
    • 54749135440 scopus 로고    scopus 로고
    • Serum levels of YKL-40 increases in patients with acute myocardial infarction
    • C. Nojgaard, N.B. Host, and I.J. Christensen Serum levels of YKL-40 increases in patients with acute myocardial infarction Coron Artery Dis 19 2008 257 263
    • (2008) Coron Artery Dis , vol.19 , pp. 257-263
    • Nojgaard, C.1    Host, N.B.2    Christensen, I.J.3
  • 33
    • 43549117072 scopus 로고    scopus 로고
    • Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
    • B. Zethelius, L. Berglund, and J. Sundstrom Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
    • (2008) N Engl J Med , vol.358 , pp. 2107-2116
    • Zethelius, B.1    Berglund, L.2    Sundstrom, J.3
  • 34
    • 57549110416 scopus 로고    scopus 로고
    • Ethical authorship and publishing
    • A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
    • (2009) Int J Cardiol , vol.131 , pp. 149-150
    • Coats, A.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.